SC 13G/A: Xilio Therapeutics, Inc.
Ticker: XLO · Form: SC 13G/A · Filed: Nov 12, 2024 · CIK: 1840233
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Xilio Therapeutics, Inc..
Risk Assessment
Risk Level: low
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on November 12, 2024 regarding Xilio Therapeutics, Inc. (XLO).